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ABSTRACT 
IMPROVEMENT OF FUNCTIONAL BIOACTIVITY IN PEAR: BLACKBERRY 
SYNERGIES WITH LACTIC ACID FERMENTATION FOR TYPE 2 DIABETES AND 
HYPERTENSION MANAGEMENT 
SEPTEMBER 2013 
NICHOLAS PUCEL, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Kalidas Shetty 
 
 Type 2 diabetes mellitus (T2DM) is a chronic disease that has a worldwide 
prevalence which is expected to rise dramatically over the course of the next thirty 
years. The disease has reached pandemic stages of development in many countries, 
most notably in developing countries, followed somewhat closely by developed 
countries with access to an overabundance of refined carbohydrates and fat (refined 
oils). T2DM is a condition that can be prevented or managed, but not cured; 
therefore a method of stymieing the development of this disease is paramount to 
halting its progressively increasing morbidity. An effective method of halting and 
delaying type 2 diabetes is refining the diet of at-risk people to limit refined 
carbohydrates and include fresh whole food produce with multiple bioactive factors 
beyond basic nutrients. In this study, Bartlett pear and Kiowa blackberry were 
investigated in relation to their potential ability to modify and improve both glucose 
metabolism and hypertension management with in vitro assay models. Effectiveness 
and bioactive functionality was evaluated by various in vitro assays to study the 
properties of: 100% Bartlett pear juice, 100% Kiowa blackberry juice and a ratio of 
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70:30 pear: blackberry juice found to have increased phenolic properties due to 
synergy in previous studies. These in vitro assays aimed at determining: alpha-
amylase and alpha-glucosidase inhibition, angiotensin converting enzyme 
inhibition, total soluble phenolic content and antioxidant capabilities. These juices 
were also fermented with Lactobacillus helveticus and Bifidobacterium longum, 
common yogurt culture strains, to investigate if fermentation would improve the 
bioactive functionality of pear: blackberry synergies. A secondary goal of the 
experiment was to investigate if these fruit juices could prevent the growth of 
Helicobacter pylori, which is a common bacterium found in the stomach which can 
lead to ulceration and cancer.  
 Overall, fermentation increases the stability of phenolic compounds in pear 
and blackberry juices, as well as the 70:30 pear: blackberry combination. This leads 
to better stability for the juices in respect to their inhibition of investigated 
enzymes. Antioxidant activity and phenolic content was also increased overall with 
fermentation along with the inhibition of alpha-glucosidase. Angiotensin converting 
enzyme inhibition was increased overall as well, which would alleviate potential 
hypertension. Fermentation of 100% blackberry with L. helveticus and B. longum 
was also shown to inhibit H. pylori. Determining the mechanisms in which these 
enzymes are inhibited in vitro will allow research to continue in vivo with animal 
models, with clinical implications. 
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CHAPTER 1  
INTRODUCTION 
Non-communicable chronic diseases (NCD) are becoming more prevalent 
every year on a global scale, and one of the most common and quickly growing 
pandemics is type 2 diabetes (T2DM). The United States has a high prevalence of 
T2DM, totaling 13.7% in men and 11.7% in women as reported in 2009. The amount 
of cases varies by state, and have the highest concentration in Southern states (I.E: 
Mississippi, Louisiana, Texas) and the lowest in Northern states (I.E:  Vermont, 
Minnesota, Montana) (Danaei, 2009). According to the World Health Organization 
(WHO), 80% of all people suffering from T2DM come from low to middle-income 
countries. Some notable countries in this category are India and China, who have the 
two greatest populations and large percentage of diabetes sufferers as well. (WHO, 
2011) According to the International Diabetes Foundation, the amount of people 
diagnosed with T2DM in India is around 62 million, China has about 90 million. The 
United States has only 21 million citizens suffering; but as a percentage the United 
States has 9.6% of the population afflicted, while India and China have only 9.2% 
and 9% respectively (IDF, 2011). Deaths caused by diabetes are expected to double 
by the year 2030; this is a substantial increase of deaths on a global scale, it requires 
attention and intervention (WHO, 2011).  
T2DM and all of its associated illnesses can be directly caused by oxidative 
stress, which mainly takes place intracellularly. Mitochondria, which are present in 
every cell in the oxygen-dependent eukaryotic organisms, are the greatest source of 
oxidants. Some of mitochondrial oxidants which are produced during respiration 
are: hydrogen peroxide, hydroxyl radicals, and superoxide (Shigenaga et al., 1994; 
Paliyath, 2011).There are natural antioxidant counters to these oxidative 
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compounds that exist within the cell, but these can potentially be overwhelmed and 
evaded by the oxidants. These escaped oxidative entities can potentially affect 
nucleic acids which in turn can cause a breakdown of the cell wall and cellular 
organelles (Ames et al. 1993; Paliyath, 2011). 
There have not been any direct genetic ties found for the cause of T2DM, but 
there are other genetic issues that can increase the chance of developing the disease. 
Having a genetic predisposition to obesity, especially intra-abdominal fat 
accumulation, is one of the most recognized causes of T2DM. Intra-abdominal fat 
has been shown to decrease insulin sensitivity in the body, which can eventually 
lead to development of T2DM (Kahn, 2003).  
Insulin resistance is one of the main causes of T2DM, along with pancreatic 
beta-cell dysfunction. When these two issues combine, they render the body unable 
to regulate sugar by itself. The typical response of the pancreas to increased insulin 
resistance will be to increase the production of beta-cells; therefore allowing for 
more insulin to be created to compensate for the resistance. Increased production of 
beta-cells and insulin then causes additional stress on the pancreas, which can 
ultimately lead to beta-cell dysfunction. Should the increased beta-cell production 
falter, the result will be the inevitable development of T2DM (Hajer et. al. 2008). 
Blood glucose is a critical balance in the body as well, and insulin plays a major role 
in the glucose homeostasis. Hyperglycemia is defined as having > 100mg glucose per 
dL of blood (Wilson, 2005). 
 One of the most common occurrences of hyperglycemia is postprandial 
increase of the blood glucose level, which occurs directly after a meal is consumed. 
After eating foods, the sugars are metabolized and directed into the blood for 
distribution throughout the body. Enzymes in the saliva and intestines, notably 
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alpha-amylase and alpha-glucosidase, break down soluble carbohydrates and 
rapidly increase sugar levels in the blood. Insulin helps regulate this blood sugar, 
but the effect will be insufficient if there is an insulin deficiency (van der Berghe, 
2003). Hyperglycemia can cause several imbalance and leads to physiological 
disorders like loss of bowel motility (Björnsson, 1994), microvascular diseases, 
macrovascular diseases, and blood gas imbalances (Marfella, 2000). In essence, the 
ability of the body to control sugar in the blood stream has a direct impact on a 
person's overall health in both acute and chronic ways. 
 The methods in which sugars are absorbed into the bloodstream within the 
intestines should also be touched upon, as it relates directly to the research being 
presented in this thesis. Carbohydrates that are ingested inevitably end up in the 
intestines, where the majority of absorption into the bloodstream occurs. The 
intestines contain pancreatic enzymes that break down these complex 
carbohydrates into simple monosaccharides that can be easily taken into the 
bloodstream through the epithelial wall. Multiple enzymes contribute to the 
complete breakdown of carbohydrates, with two of the most important being alpha-
amylase and alpha-glucosidase which break down amylose and glycogen, 
respectively. The action of these two enzymes is critical to the absorption of glucose 
into the body, inhibiting them can improve post-prandial blood sugar levels. Alpha 
amylase works by cleaving alpha 1,4 bonded glucose molecules within the starch 
structure, acting as an endo-amylase (van der Maarel, 2002) This in turn breaks the 
large, branched amylose into smaller sections which are easier for other enzymes to 
handle. Alpha-glucosidase, on the other hand, breaks maltose in half – which is a 
disaccharide comprised of two glucose molecules. In essence, the alpha-glucosidase 
can break two glucose molecules apart in the middle of an amylose chain or break 
apart the maltose disaccharide itself. This leads to either the formation of two 
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smaller amylose chains or to the creation two new glucose molecules, which can 
rapidly increase blood sugar levels through faster absorption into the intestine. 
 Pharmaceutical drugs can be utilized to prevent sugar uptake into the 
bloodstream, but it is not always the best option. Many pharmaceutical options for 
sugar blocking can inhibit alpha-amylase and alpha-glucosidase entirely. While this 
may seem like an extremely effective method for preventing sugar uptake, it has  
many side-effects in the body. Not only do the calories from the sugars get blocked; 
but they also end up being shunted through the small intestine and into the large, 
where gut bacteria will utilize them for fermentation. This fermentation can have 
negative repercussions on the body, including gastric distress and irritable bowels. 
In order to curb but not eliminate the uptake of sugars into the blood, alpha-amylase 
and alpha glucosidase can be inhibited using natural compounds from plant sources, 
especially fruits and vegetables.  
 Cardiovascular diseases (CVD) are often associated with diabetes and the 
cost of treating heart problems exceeds $100 billion dollars every year (DeFronzo, 
1999). This leads researchers to believe that each of the diseases can actually cause 
the other to occur in patients. In a study, it was shown that using ACE blockers in 
patients with hypertension, the rate that the patient developed T2DM was lowered 
from 34% to 11% (Sowers, 2001). The rate of developing T2DM from having 
hypertension is very large, having one out of three patients develop it from this 
study. Inhibiting ACE seems like a significant step to prevent the development, 
reducing the occurrence of diabetes in this example by about 66%. 
 Many plant-sourced compounds have been studied for use in dietary 
management of carbohydrate-based calories, their metabolism and for general 
health benefits. Phenolic compounds from fruits and vegetables play a very 
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important role in management of blood sugar by their inhibitive properties on gut 
enzyme activity. For this specific study, pears and blackberries were chosen as the 
source of phenolic compounds. Phenolics from the Bartlett pear and the Kiowa 
blackberry have been shown to dramatically inhibit the activities of alpha-amylase, 
alpha-glucosidase and angiotensin converting enzyme in vitro. With a ratio of 70% 
Bartlett pear to 30% Kiowa blackberry, there has been an impressive level of 
inhibition in regards to alpha-amylase and alpha-glucosidase, along with a low to 
moderate decrease in the activity of angiotensin converting enzyme II (ACE) 
(Warner, 2012).  ACE activity can lead to cardiovascular issues and chronic heart 
disease by causing hypertension and other related effects via the renin-angiotensin-
aldosterone pathway (Weir, 1999). Phenolics have been shown to limit the effects of 
these enzymes by binding to their active sites, therefore preventing enzymatic 
action (Matsui et al., 2001). 
  By inhibiting ACE to prevent hypertension and inhibiting alpha-amylase and 
alpha-glucosidase to prevent expedited sugar uptake, there is potential to prevent 
the prevalence of chronic diseases. Pear has a high level of ACE inhibition, but low 
alpha-amylase and alpha-glucosidase inhibitory activity. Blackberry, on the other 
hand, has a high amount of alpha-amylase and alpha-glucosidase inhibition but no 
ACE inhibition (Warner, 2012). These fruits can supplement each other and cause a 
synergistic effect to occur when combined. 
 Fermentation of foods has been used for thousands of years for a variety of 
reasons; the most important being for preservation of the foods, but fermentation is 
also important for flavor and health benefits. Multiple beneficial nutrients such as 
vitamins or phenolic compounds can be added or made available by different types 
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of microorganisms. There is a notable increase in vitamin B content during most 
fermentation processes (Tongnual and Fields, 1979; Paliyath, 2011). 
 Fermentation can be utilized to further alter the phenolic profile of the fruit 
juices. The bacteria used to ferment the pear and blackberry used in this study is a 
lactic acid bacterium (LAB); Lactobacillus helveticus. This bacterium, as its name 
suggests, produces lactic acid from sugars but can also produce other organic 
compounds. These acids and compounds can interfere with enzymatic activity, but 
can also be beneficial. This particular strain of bacteria is often found in fermented 
dairy products used in the United States.  
 A second LAB has also been investigated in this study in order to determine if 
different effects would occur regarding enzymatic inhibition if the fermentative 
organism was altered. The second bacterium, Bifidobacterium longum, is another 
commonly used culture for yogurt production. It ferments sugars into lactic acid in a 
similar manner to Lactobacillus helveticus, but as a different organism it will react 
differently to the provided environment and conditions. Having a second LAB allows 
comparison between the two and to check for consistencies. The second bacterium 
can also open up the possibilities of having multiple bacteria with different 
properties being combined for their collective health benefits and potential 
symbiotic relationships. 
Probiotics have become more and more popular over the past few years, and 
their potential to be utilized by food and health industry is growing along with their 
popularity. Good probiotic bacteria will colonize the intestinal tract and help 
increase gut health. The increases in health are usually due to an increase in 
metabolic stability and increased resistance to pathogen uptake and colonization 
(Holzapfel, 1998). Lactobacilli have often been used as a probiotic addition to foods, 
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and show very promising results when used as such. Lactobacilli are acid tolerant 
bacteria, and can therefore easily survive the early stages of digestion prior to 
colonization. These bacteria can ferment foods and provide additional benefits upon 
consumption besides being purely probiotic. In a study conducted upon rats, the 
ingestion of lactobacillus containing fermented milk both decreased cardiovascular 
disease and increased the time it took the rats to develop glucose intolerance 
(Holzapfel, 1998). 
Helicobacter pylori is a harmful bacterium that is commonly found in the 
stomach and duodenum of humans. This bacterium can cause ulceration and, if left 
unchecked, can lead to stomach or duodenal cancers via the aggravation of cellular 
breakdown. Along with the health benefits of these fruits being studied in respect to 
type 2 diabetes mellitus, the potential of the fruit juices in regards to inhibiting H. 
pylori was also examined; with and without the fermentation by L. helveticus 
(Montecucco, 2001). 
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CHAPTER 2 
REVIEW OF LITERATURE 
2.1: Type 2 Diabetes: Pathophysiology 
 Beta-cell dysfunction and insulin resistance have been attributed to the two 
major causes of developing T2DM. As insulin resistance increases, insulin sensitivity 
decreases; which in turn causes insulin to become less effective. Beta-cells in the 
pancreas begin to dysfunction as this process occurs with the insulin due to the 
increased insulin production that is signaled for by the body, which leads to the end 
result: the development of T2DM. Beta-cell dysfunction occurs prior to the 
development of T2DM and not during the onset of the disease. This was discovered 
via oral glucose tests on both diabetic and non-diabetic subjects. This indicates that 
beta-cell dysfunction could be a primary cause of T2DM and not just an aftereffect 
(Kahn, 2003). 
To truly understand how T2DM begins in the human body, one must first 
understand how insulin functions. Another way to look at the development of T2DM 
is to understand how insulin deficiencies occur – and how they affect the body. 
Hyperglycemia is one of the ways that insulin resistance develops, and 
hyperglycemia can be caused by a multitude of factors. Hyperglycemia can simply 
occur due to the consumption of food, but can also be caused by injuries or acute 
trauma and its effects have been coined as the “diabetes of injury”. Insulin 
administered after injury helps prevent glucose toxicity and further damage to the 
critically injured. Excessive glucose can cause oxidative stress due to extreme 
amounts of phosphorylation and glycolysis at the cellular level. Insulin resistance is 
detrimental to the well-being of a person, and is a strong symptom of diabetes. The 
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cause of the resistance can reach beyond just nutrition, it is important to study these 
other causes as well as the main diet related ones (van der Berghe, 2003) . 
 Postprandial hyperglycemia can lead to many issues and complications 
beyond insulin resistance. Atherosclerosis is a common disease caused by 
postprandial which leads to oxidative stress and redox imbalance. Cardiovascular 
diseases are a very common cause of death and disability in the United States. 
Postprandial hyperglycemia is common, but controlling the diet and caloric intake 
by practicing moderation can help with preventing complications due to this form of 
hyperglycemia. Oxidative stress can also occur due to these metabolic effects on the 
mitochondria within cells which cannot refuse the ample sugar of the blood to 
create reactive oxygen species. This oxidative stress can lead to further 
complications and health risks along with the increased chance of developing T2DM 
(Ceriello, 2000). 
 Wilson (2005) took a deeper look into the metabolic syndromes in relation to 
T2DM and cardiovascular disease. The study focused on five main traits: abdominal 
adiposity, low HDL (high-density lipoprotein) cholesterol, high triglycerides, 
hypertension and impaired fasting glucose. This study followed over 3000 middle-
aged adults, the adults that developed at least three of the five traits showed 
conclusive results. The prevalence of at least three out of the five previously 
mentioned metabolic syndromes in these adults was 26.8% for men and 16.6% in 
women.  This shows that metabolic syndromes are very common in adults and 
therefore the prevalence of cardiovascular disease and T2DM is likewise as common 
or at least a high-risk pair of diseases for the average adult (Wilson, 2005) . 
 Studies have found that adipose tissue in the body can actually affect glucose 
and lipid metabolism rates. These tissues can also release hormones which can 
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further affect body functions. Increases in the prevalence of adipose tissue have also 
increased the prevalence of T2DM and cardiovascular diseases. Studies by Hajer 
(2008) have shown that these observations are accurate, and that these 
accumulations of intra-abdominal fat have adverse effects on the body as a whole. 
Adipose tissue was shown to act as an actual endocrine organ which plays a very 
important role in the metabolism of lipids and glucose. The hormones that adipose 
tissue can produce are directly correlated to the development of T2DM and 
cardiovascular diseases. Managing obesity rates can help manage these dysfunctions 
if only due to the management of the adipose tissue itself (Hajer et. al. 2008).  
2.2: Oxidative Stress and Type 2 Diabetes 
 Oxidative stress is an extremely damaging event that occurs naturally in cells 
due to their natural respiration processes, which can lead to detrimental health 
consequences such as CVD and T2DM. The source of most oxidative compounds is 
the mitochondria, which is a critical organelle that is used for cellular respiration, 
and also the oxidation reduction reactions which occur during respiration. About 
85% of the oxygen used in the cell is due to the mitochondrial electron transport 
system. The mitochondria produce ATP for energy through oxidative 
phosphorylation, which is an oxidation reduction reaction. Over time, the oxidation 
caused by the by-products of the mitochondrial electron transport chain can 
damage cells and cellular organelles and lead to cellular dysfunction. Oxidants like 
superoxide, peroxides, singlet oxygen, and hydroxyl radicals can be produced. This 
is actually the main cause of aging. All of these by products must be dealt with using 
antioxidants within the cell, or else the damage caused can lead to metabolic 
breakdown. It is paramount to the health of the cell to contain enough antioxidants 
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in order to quench all oxidants that are present. Balancing oxidants and antioxidants 
will lead to cellular homeostasis, a requirement for cell health and longevity.  
Oxidative stress can increase the damage done by obesity by both having an 
increased prevalence in the body and by occurring in adipose tissue. Obesity causes 
an increase in free fatty acids (FFA) within the body. FFA has the ability to impair 
glutathione, a common and effective intracellular antioxidant inhibition of 
glutathione by FFA increases oxidative stress at an intracellular level. These FFA can 
also damage mitochondrial function such as uncoupling oxidative phosphorylation 
or by causing the production of superoxide and other reactive oxygen species (ROS) 
(Evans, 2003). ROS have also been shown to be produced in adipose tissue, which 
can lead to more oxidative stress on the body. Higher levels of adipose tissues have 
also been shown by Furukawa (2004) to cause reduced antioxidative enzyme 
production and increased expression of NADPH oxidase which is an oxidizing 
enzyme. The combination of increased ROS production and reduced antioxidants 
can lead to the development of the metabolic syndrome (Furukawa, 2004).  
Shingenaga et al. (1994) found that oxidative damage could occur over time 
in a variety of cells after exposure to oxygen, and could be caused by a variety of 
oxidative compounds. The researchers looked for lipofuscin, which is a marker of 
oxidative damage. When lipofuscin is present, it is determined that oxidative 
processes have occurred in the cell and have resulted in damage to the organelles, 
nucleus or membrane. Electron transport is also damaged by oxidation, and this can 
cause further production of both hydrogen peroxide and superoxide. This is a chain 
reaction effect that ends up causing extra production of oxidants. These oxidants 
may increase the rate of metabolic breakdown which leads to T2DM, along with 
increasing oxidative stress on the body. Mitochondrial damage can also lead to 
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immune system decay and nuclear damage, which can lead to genetic mutations and 
can progress the metabolic syndrome (Shigenaga et al., 1994; Paliyath, 2011).  
2.3: Antioxidants and their Effects on Stress Induced Metabolic Disorders 
 Using natural antioxidants provided by fruits and vegetables is an efficient 
method to counter oxidative stress-induced diseases such as T2DM. It was shown by 
Soobrattee (2005) that many natural compounds, including phenols and vitamins, 
scavenged oxidants and exhibited protective and beneficial effects against oxidation. 
In the research, it was shown that protection of the cardiovascular system by the 
proanthocyanidin rich extract included: (1) potent hydroxyl and other free radical 
scavenging abilities; (2) antiapoptotic, antinecrotic and antiendonucleolytic 
potentials; (3) modulation of apoptotic regulatory bcl-XL, p53 and c-myc genes; (4) 
cytochrome P450 2E1 inhibition; (5) inhibition of proapoptotic, cardioregulatory 
genes c-JUN and JNK-1 and (6) the inhibition of constriction of smooth heart 
muscles and the endothelium (Soobrattee, 2005). 
 Phenolic compounds and other plant-based antioxidants have been shown to 
be an effective means of alleviating metabolic disorder through improved redox 
balance. Rahimi (2005) has noted that flavonoids from plants are adept at 
scavenging free radicals in the body. Compounds like quercetin have been shown to 
be effective ion chelators as well. Reactive metals can increase the rate of oxidation 
within the body, so chelating compounds are a welcome source of relief to this issue. 
Plants are also a great source of antioxidative vitamins, such as beta-carotene (as 
provitamin A), ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E). 
Increasing the dietary intake of plant based phenolics and antioxidants is a proven 
diet-based preventative measure in combating T2DM. These same phenolics have 
many effects on the glucose metabolism, which include the inhibition of key starch-
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digesting enzymes. Inhibiting these enzymes helps lowering sugar uptake into the 
bloodstream and can therefore help with regulating insulin production in the 
pancreas and reduce the system shock factor from quickly absorbed refined sugars. 
One of the most important enzymes pertaining to the digestion of starch is alpha-
amylase, which quickly breaks amylose chains into smaller and more easily 
dissolved fractions (Rahimi 2005). 
2.4: Alpha-Amylase and its Role in Glucose Metabolism 
 In a review by van der Maarel (2002), alpha-amylase and its applications 
were explored. As the name implies, the alpha-amylase enzymes attack alpha bonds 
on amylose structures. These alpha bonds connect glucose residues together; when 
they are broken the glucose can then be taken away from the larger amylose for use 
by organisms. Van der Maarel (2002) noted at least 21 different bond specificities in 
the alpha-amylase enzyme family. This means that there are over 21 different types 
of enzyme, each specialized in breaking a specific type of glucose bonding. There are 
two main varieties of alpha-amylase; one being starch-hydrolyzing enzymes which 
can break apart the amylose, while the other type is starch-modifying enzymes that 
will simply change conformations within the amylose. Each different alpha-amylase 
could be used for various applications, but they are all useful for starch modification 
and digestion. (van der Maarel, 2002)  
 There are multiple forms of alpha-amylase enzyme that exist in the human 
body. Humans use these to digest carbohydrates and extract the glucose and other 
sugars from them. The enzymes exist in both salivary fluids within the mouth and 
pancreatic fluids within the intestines. Both alpha-amylase sources produce 
different enzymes varieties pertaining to various bond structures which need to be 
broken down within the food which humans consume. In a study by Hagele (1982), 
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it was found that the pancreatic alpha-amylase enzyme cleaved 9% of amylose 
between the second and third glucose unit, 31% between the third and fourth, and 
60% between the fourth and fifth. The corresponding results for the salivary alpha-
amylase enzyme are 10, 26, and 64% respectively. These two enzymes both function 
in a similar method, but at slightly different ratios. It was also shown that the 
salivary enzyme worked around twice as fast as the pancreatic enzyme did. This 
may be due to the fact that since the food spends such a long time in the intestines 
that it would be more beneficial to the body to prevent a quick sugar uptake at the 
start of digestion. Alpha-amylase does not fulfill the entire role of starch digestion 
since it has a difficult time of breaking the starch down into single glucose 
molecules. In this respect, alpha-amylase requires a co-enzyme to complete starch 
breakdown, namely alpha-glucosidase. (Hagele 1982)  
2.5: Alpha-Glucosidase and its Role in Glucose Metabolism 
 Alpha-glucosidase is an oligosaccharide-hydrolase that can break down both 
carbohydrates and glycogen in lysosomes. This enzyme can produce the alpha form 
of glucose out of the more complex substrates which humans consume. It completes 
this reaction by hydrolyzing bonds within the carbohydrate.  Chiba (1997) has 
found that alpha-glucosidase hydrates the double bond of D-glucose to produce 2-
deoxy-D-glucose. The enzyme protonates the C2 position of D-glucose from different 
directions, being either above or below the plane (alpha or beta). Alpha-glucosidase 
works alongside with alpha-amylase to fully break down starches; since each 
enzyme can attack different parts of the substrate, the combined efforts of both can 
complete a more full degradation of the carbohydrate. Alpha-glucosidase also 
facilitates glucose absorption in the intestines. Inhibiting these enzymes will be 
paramount in mediating glucose absorption rate to alleviate postprandial 
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hyperglycemia. An effective way to do so is by utilizing plant-based phytochemicals, 
particularly phenolics through consumption of edible plants. (Chiba, 1997) 
2.6: Phenolics and Glucose Metabolism 
 Phenolic compounds are a diverse species of secondary metabolites of plants 
that range in size, function and composition. There are many of these in fruits and 
vegetables that work as antioxidants or enzyme inhibitors. Humans can reap the 
beneficial properties of the plant-based phenolic compounds by utilizing them as 
diet to tolerate biotic and abiotic stresses. These phenolics have been shown to be 
able to inhibit alpha-amylase and alpha-glucosidase, which for the plant would act 
as a pest deterrent to prevent a pest from digesting the sugars and controlling 
overall metabolism in relation to environmental adaptation. In a human body when 
consumed, phenolic inhibitors act to slow down postprandial hyperglycemia and 
delay the time it would take to digest and absorb sugars into the bloodstream. High 
alpha-glucosidase and moderate alpha-amylase inhibition has been shown to 
potentially have the best postprandial hyperglycemia control by Cheplick (2010) in 
a phenolic rich strawberry. Excessive alpha-amylase inhibition has been shown to 
lead to undigested starch in the intestines, which can lead to an irritated feeling in 
the gut. This is due to the fact that starch will not be broken down sufficiently in the 
small intestine, which leads it to be broken down by bacteria in the large intestine. 
When bacteria break down starch, they create gases which can lead to bloating and 
other discomforts (Cheplick et. al. 2010).  
 Phenolics from plants have been shown to inhibit glucose absorption in 
studies by McCue et al (2004). The study done by McCue et al (2004) alluded to the 
fact that phenolic extracts, in this case rosmarinic acid, from plants can inhibit 
alpha-amylase in vitro anywhere from around 50% (natural source) or up to around 
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90% (concentrated extract). Slowing alpha-amylase potentially slows the entire 
glucose absorption pathway in the digestive tract by limiting the amount of areas 
that alpha-glucosidase can affect. Limiting alpha-glucosidase activity effectively 
slows the rate that single glucose molecules will be pulled from the starch chain. The 
chain-reaction from limiting enzyme activity can drastically decrease sugar 
absorption into the blood and therefore decrease the effects of postprandial 
hyperglycemia which can lead to diabetes, the metabolic syndrome and potential 
cardiovascular issues (McCue et al 2004). Phenolic compounds also play an 
important role in glucose absorption by affecting enzymatic activity and oxidation-
reduction reactions. This in turn alters beta-cell function as insulin is produced at 
more controlled intervals and at lower quantities (Hannineva et. al, 2010) 
2.7: Cardiovascular Disease in Relation to Type 2 Diabetes 
 T2DM can lead to many complications which can become life-threatening. 
The cardiovascular system suffers greatly due to T2DM, and people afflicted by 
T2DM often develop dyslipidemia, hypertension, obesity, clotting abnormalities, 
microalbuminuria, and accelerated atherosclerosis (Defronzo, 1999). These 
cardiovascular issues can be deadly and devastating and the chance to develop them 
is greater due to suffering from T2DM. These complications are all coupled with the 
insulin resistance syndrome, also called the metabolic syndrome or syndrome X. 
Cardiovascular disease accounts for the most deaths due to T2DM, which are often 
due to the increased levels of sugars and lipids that are present in the bloodstream 
(DeFronzo, 1999). 
 Diabetes mellitus is often referred to as a comorbid disease due to the 
multitude of metabolic breakdowns and complications that it causes, and can also be 
caused by. In a study that was touched upon by Sowers, 2001 the chance of 
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developing T2DM was 2.5 times as likely to occur within patients suffering from 
hypertension than those without the complication. T2DM, likewise, also greatly 
increases the chance of developing hypertension. Cardiovascular disease accounts 
for around 80% of the deaths in humans with T2DM, and mortality is 7.5 times 
greater within the T2DM afflicted population without a previous myocardial 
infarction than those without the disease. The presence of hypertension and T2DM 
greatly increases the chance of developing serious cardiovascular complications 
(Sowers, 2001). 
2.8: Angiotensin I Converting Enzyme (ACE) in Relation to Hypertension and 
Oxidative Stress 
 One way to control hypertension is by utilizing ACE inhibiting compounds. 
ACE, or angiotensin I converting enzyme, converts inactive angiotensin I in the body 
into angiotensin II.  Angiotensin II stimulates the synthesis and release of 
aldosterone from the adrenal cortex, which then increases blood pressure via 
promoting sodium retention. This is called the renin-angiotensin-aldosterone 
pathway, and it naturally helps regulate blood pressure. The issue lies in when there 
is too much production of ACE. In past investigations, it has also shown that 
angiotensin II also stimulates the production of superoxide anion and hydrogen 
peroxide in the polymorphonuclear leucocytes, which in turn causes oxidative stress 
on the system. There are many stressors associated with ACE, inhibiting the enzyme 
will reduce a significant amount of hypertensive stress and oxidative damage 
(Barbosa-Filho et al., 2006; Nielsen, 1991). 
 Utilizing natural ACE inhibitors from plant-based sources are more attractive, 
due to the fact that most pharmaceutical drugs fully inhibit many other digestive 
enzymes as well as ACE. With this in mind, research has been done on utilizing food 
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sources to inhibit ACE. In studies performed by Kwon (2006), it was shown that 
many edible plants have the ability to safely inhibit ACE. In fact, this research 
showed that some plant phenolic extracts can inhibit ACE by up to 90% in vitro. 
Dietary management of hypertension is a natural and safe method to utilize in 
contrast to over-the-counter drugs which can end up causing intestinal discomfort 
(Kwon, 2006; Barbosa-Filho et. al, 2006) 
2.9: Fermentation with Lactic Acid Bacteria 
 Fermentation of foods using lactic acid bacteria can improve the antioxidant 
capacity of phenolic compounds. It was shown by Rodriguez (2009) that by using 
lactic acid bacteria in food, L. plantarum specifically, the amount of tannins and 
phenolic acids decreased significantly. This was due to the activity of tannases and 
phenolic acid decarboxylases, two types of enzymes utilized by the bacteria. These 
broken down tannins and phenolic compounds can be subsequently converted to 
antioxidant compounds (Rodriguez et. al. 2009).  
 Lactic acid bacteria are the most commonly used traditional starter cultures 
by humans for fermentation processes. Their ability to be used as a probiotic adds 
an additional health benefit to utilizing LAB as a fermenting organism. The term 
“probiotic” is sourced from the Greek language, where it translates to “life”. The 
term has recently been used to describe a microbe that, when ingested in sufficient 
numbers, can help regulate an animal's intestinal microflora. This regulation is 
achieved by the production of compounds by the probiotic bacteria that are harmful 
to pathogenic organisms and prevention of pathogen attachment to the epithelial 
wall of the intestines. Other probiotic benefits of note are their potential to 
metabolize nutrients for the host and alleviation of bowel disorders. (Ankolekar, 
2011) 
19 
 
2.10: Probiotics and their Benefits to the Digestive System 
 Lactic acid bacteria consumed in the diet can act as a probiotic. Probiotics are 
important for both maintaining gut health and sustaining healthy microflora in the 
intestines. Holzapfel (1998) has described multiple benefits in having strong gut 
microflora, including: prevention of pathogenic adherence to the intestinal walls, 
modification of dietary proteins, modification of bacterial enzyme capacity, and 
influence of gut mucosal permeability. Gut microflora make pathogens to have a 
more difficult time of infecting the host, help with monitoring the diffusion of 
compounds into the bloodstream, and help digesting foods via enzyme bolstering. 
Lactobacillus helveticus is useful for improving gut microflora as a probiotic when 
consumed. When a fruit juice is inoculated with L. helveticus, it would retain the 
beneficial effects of the fruit and gain the beneficial probiotic attributes of a lactic 
acid bacterium (Holzapfel, 1998). 
2.11: Lactobacillus helveticus as a Fermentative Organism 
 Previous work by LeBlanc (2002) has shown that sarcoma occurrences can 
be lessened when milk which has been fermented with L. helveticus is ingested to 
mice. This study shows that multiple immune response abilities are heightened by 
the presence of L. helveticus metabolites in fermented dairy products. This seems to 
be relative to the phagocytic index of the fermented product, or the ability of the 
food to increase phagocytosis in the host. Phagocytosis in this case refers to the 
enveloping of pathogenic organisms via immune system cells such as IgA (LeBlanc, 
2002). 
 In a study by Johnson-Henry (2006), protein extracts that were taken from L. 
helveticus were shown to inhibit the adhesion of pathogenic E. Coli O157:H7 onto 
the epithelial wall of the intestinal tract. Adhesion is one of the most important steps 
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of bacterial infection in the digestive system, inhibiting the ability of pathogens to 
attach to intestine cells can greatly reduce the chance of contracting a disease. The 
mechanism for the inhibition of adhesion seems to simply be competition for 
binding sites on the epithelial wall. When L. heleveticus is consumed, it will block off 
the sites of the epithelial cell prior to the ingestion of E. Coli O157:H7 (Johnson-
Henry, 2006). 
 Lactobacillus helveticus is a lactic acid bacterium that is often used in the 
fermentation of milk products. This bacterium can also be used with fruit, and has 
shown positive results for antioxidant activity in previous studies. In research done 
by Ahire et al (2011), oxidation of ascorbate was reduced by 27.5±3.7%. L. helveticus 
exudates also scavenged 20.8±0.9% of hydroxyl radicals. These results are 
promising for the effectiveness of lactic acid fermentation, and especially for L. 
helveticus (Ahire, 2011). 
 Studies by Mousavi (2010) have shown that probiotic lactic acid bacteria can 
survive in refrigerated temperatures when introduced to fruit juices. Lactic acid 
bacteria were viable for up to three weeks in refrigerated temperatures; ergo the 
drink would be perishable in regards to the probiotic benefit. Mousavi (2010) found 
that the bacteria utilize citric acid as their main source of carbon during 
fermentation, which is in abundance for most fruits. Lactic acid bacteria also 
metabolized both glucose and fructose within the fruit juice, which means that the 
bacteria are not overly selective when it comes to sugar substrates. This study lends 
viability to the idea of a probiotic fruit drink utilizing Lactobacillus helveticus and 
Bifidobacterium longum  (Mousavi, 2010). 
In previous research, L. helveticus has been found to be a beneficial organism 
when placed into fruit juices. Fermentation with L. helveticus has been shown to 
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increase functionalities in potentially managing the metabolic syndrome during 
early stages of Type 2 diabetes. In the previous studies, apple and blueberry juice 
combinations along with cherry and pear juices were used and the bacteria 
successfully grew to a high enough levels to function as a probiotic when ingested 
(Augustinah, 2012; Ankolekar, 2011; Apostolidis et al., 2006) 
2.12 Bifidobacterium longum as a Probiotic Organism 
 Bifidobacterium longum is a lactic acid bacterium that is commonly utilized as 
a live culture probiotic in foods, much like L. helveticus. This organism has been 
shown by Harmsen (2002) to work as a probiotic in human subjects, and has also 
been demonstrated to be GRAS, or "generally regarded as safe" (Harmsen, 2002). In 
regards to the bacterium and the effect it has on diabetes symptoms, Chen, 2008 has 
shown that the presence of this microorganism in the digestive tract can lead to 
improved insulin resistance and the lowering of metabolic inflammation. Rats were 
fed a high-fat diet and then either fed B. longum or not fed any probiotic at all. Rats 
which were fed the B. longum had lower incidences of the metabolic syndrome 
(Chen, 2008). While the testing by Chen (2008) was performed on rats, the results 
are likely a close analog to the effects on a human digestive system. 
In previous research, B. longum has been found to be a beneficial organism 
when combined with fruit juices. Fermentation with B. longum has been shown to 
increase functionalities in potentially managing the metabolic syndrome during 
early stages of Type 2 diabetes. In the previous studies, apple and blueberry juices 
were used and the bacteria successfully grew to a high enough level to function as a 
probiotic when ingested (Augustinah, 2012).  
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CHAPTER 3  
OBJECTIVES 
3.1: Main Objectives 
 
 The major goals of this thesis research are as follows: 
To evaluate using in vitro assays the change in ability of Bartlett pear extract, Kiowa 
blackberry extract, and a ratio 70:30 pear/blackberry extracts to potentially manage  
early stages of T2DM and CVD through the diet after fermentation by various strains 
of bacteria. 
 A second major objective was to determine if these same fermented juices 
inhibit H.pylori more than their unfermented counterparts. 
 
3.2: Specific Objectives 
 
 The specific goals derived from the main objectives are as follows: 
 
1) To evaluate the synergistic effect of pear and blackberry on in vitro 
enzyme inhibition relevant to early stages of type 2 diabetes and hypertension 
management after fermentation with Lactobacillus helveticus and also with a 
separate fermentation by Bifidobacterium longum. 
 2) To determine if these same fermented juices inhibit H.pylori more than 
their unfermented counterparts and improve gut health. 
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CHAPTER 4 
IMPROVMENT OF FUNCTIONAL BIOACTIVITY IN PEAR: BLACKBERRY 
SYNERGIES FOR TYPE 2 DIABETES AND HYPERTENSION UTILIZING 
LACTOBACILLUS HELVETICUS FERMENTATION 
 
4.1: Abstract 
 Bartlett pear and Kiowa blackberries have been shown to exhibit bioactive 
beneficial potential in regards to the management of Type 2 diabetes mellitus and 
hypertension, a common Type 2 diabetes co-factor based on in vitro assays. 
Combining these juices at a ratio of 70:30 pear:blackberry has been shown in 
previous studies to contain the highest amount of phenolic-linked activity due to 
synergistic effects. The focus of this study was to determine the effectiveness of 
lactic acid fermentation, specifically with Lactobacillus helveticus, in regards to 
preserving phenolic-linked activity over time and enhancing the health benefits of 
the juices. The secondary goal of the experiment is to validate if any fruit juice, 
fermented or not, can inhibit the growth of Helicobacter pylori, a common bacterium 
found in the gut which can cause ulceration of the stomach and duodenum and can 
subsequently lead to potential cancer development in the aforementioned organs. 
 Over the course of the study, results showed that the 70:30 combinations had 
good synergy, the highest content of soluble phenolics, higher antioxidant activity, 
and the fermentation with L. helveticus lead to higher phenolic activity retention 
over time. Fermentation increased the ability over time of phenolic compounds in 
regards to the inhibition of the studied enzymes relevant to glucose metabolism, 
showing a stabilization effect of the fermentation on the phenolics. A 100% Kiowa 
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blackberry juice was shown to inhibit the growth of H. pylori, but only after 
fermentation. The control showed no inhibition whatsoever, nor did any 70:30 
combination or 100% Bartlett pear juice show any inhibition of the bacterium 
either. The 70:30 combination is the most cost-effective way to reap the greatest 
benefits of the fruits studied. Fermentation with L. helveticus increases the overall 
effectiveness by adding bioactive stability and additional health benefits. 
4.2: Introduction 
 Lactic acid bacteria have long been used to preserve foods and prevent 
spoilage since before constant refrigeration was possible. Investigating one step 
further than spoilage prevention would be to examine the change of certain 
nutritional benefits and attributes of the fermented product. In this study, 
Lactobacillus helveticus was utilized in order to compare phenolic content and 
capabilities of a fermented fruit juice and the non-fermented counterpart. The aim 
was to increase the ability of the juice to inhibit the alpha-amylase, alpha-
glucosidase and angiotensin converting enzymes while also evaluating if the 
antioxidant functions are affected by the fermentation. The main focus of the 
experiment is to develop a beverage with bioactive benefits for managing early 
stages of Type 2 diabetes mellitus by dietary management and supplementation 
with various fruit juices. Phenolic compounds which naturally occur in fruits have 
the ability to slow the action of metabolic enzymes which digest simple 
carbohydrates such as amylose and amylopectin, which are a common and plentiful 
source of glucose. These carbohydrates are often found in inexpensive processed 
foods, which are widely consumed by the populace of the United States and the BRIC 
countries (Brazil, Russia, India, and China). Altering and slowing glucose 
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metabolism is a key approach to avoid sugar spikes in the blood, which can lead to 
Type 2 diabetes mellitus or postprandial blood sugar.  
 Glucose metabolism is the key to diabetic development; since insulin 
management is one of the most important aspects of preventing the development of 
Type 2 diabetes mellitus. When glucose is absorbed into the bloodstream, insulin is 
produced by the pancreatic beta-cells to keep blood sugar regulated. When too 
much glucose is absorbed, insulin production must also increase. The increased 
production of insulin can lead to insulin resistance, and then ultimately beta-cell 
dysfunction as the beta-cells are overworked (Ceriello, 2000). 
 Fruit juices can also inhibit the angiotensin converting enzyme (ACE), which 
can cause oxidative stress and hypertension when produced in abundance by the 
body. Hypertension is a co-factor for the development of Type 2 diabetes mellitus, 
and is often seen as a comorbid disease due to the increased chances of developing 
one of the conditions when the person already has the other. One way of developing 
hypertension is through the renin-angiotensin-aldosterone pathway which occurs 
naturally to regulate blood pressure. The angiotensin converting enzyme in the 
body converts angiotensin I, a harmless compound, to angiotensin II which 
increases blood pressure and can lead to hypertension. Managing this enzyme can 
therefore help alleviate hypertension (DeFronzo, 1999) and associated problem of 
type 2 diabetes. 
 Bartlett pear and Kiowa blackberries have been studied previously and have 
been shown to inhibit enzyme activity related to glucose metabolism (Warner, 
2012). As a support to the preservation aspect of lactic acid fermentation, another 
benefit that was examined is the change in total soluble phenolic content over time. 
Phenolic compounds inhibit the key dietary metabolism regulating enzymes and are 
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also partly responsible for the antioxidant properties of the fruit juices. The 
preservation of stability of phenolic activity over time would increase the shelf life 
of a product with regard to the nutritional properties it exhibits. This preservation 
technique could also be utilized to repurpose fruits that may not be consumed 
before their expiration, which would increase economic value and decrease losses 
due to spoilage.  
 Two different fruit juices were examined in three different combinations: 
100% Bartlett pear, 100% Kiowa blackberry, and a combination of the two at a ratio 
of 70:30 pear:blackberry. All three varieties of juice were tested in the exact same 
manner: total soluble phenolic content, 1, 1-Diphenyl-2-Picrylhydrazyl (DPPH) 
radical inhibition assay, and for the inhibition of: alpha-amylase, alpha-glucosidase 
and angiotensin converting enzyme. These juices were fermented for 48 hours total 
and examined at the zero hour, 24 hours and 48 hours for changes in bioactive 
attributes. The juices were also tested as pH adjusted to 6 (with inoculum) and as a 
control with no inoculation in tandem. Juices will also be plated after the main 
experiment on a bacterial lawn of Helicobacter pylori in order to perform an agar 
diffusion assay to determine if any fermented or non-fermented juice has the ability 
to inhibit the growth of this pathogenic organism. Inhibition of H. pylori is a 
secondary objective in the study, but positive results would prove to be an 
additional boon to the already nutritionally beneficial fruit juices. 
4.3: Materials and Methods 
 The enzymes, α-glucosidase from yeast S. cerevisiae (EC 3.2.1.20), porcine 
pancreatic α-amylase (EC 3.2.1.1) and angiotensin-1-converting enzyme from rabbit 
lung (EC 3.4.15.1) were purchased from Sigma Chemical Co. (St. Louis, MO). Unless 
noted, all chemicals were also purchased from Sigma Chemical Co. (St. Louis, MO). 
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The Bartlett pear was sourced from a local Big Y supermarket (Hadley, MA), 
while the Kiowa Blackberries were from the Auburn University (Auburn, Alabama) 
and the cultivar developed by Arkansas Agricultural Experiment Station breeding 
program. 
4.3.1: Sample Preparation 
Fresh Bartlett pears were homogenized using a Waring blender for 3 min and 
subsequently the supernatant of the pear was collected following centrifugation at 
15,000g for 15 min. Thawed blackberry fruit was homogenized for 3 min using a 
Waring blender and then centrifuged two times at 15,000g for 15 min each to 
produce a clear juice. Supernatants were collected and stored at -20 °C during the 
period of study. The pear and blackberry supernatants were either used as 100% 
pure samples, or combined at a ratio of 70/30. Pear and blackberry juice alone were 
used as controls. Some combinations and controls were prepared in the adjusted pH 
6 (with several drops of 0.1N NaOH) while some were used with natural acidic pH 
conditions. The juices were stored at 4 °C during their analysis. 
4.3.2: Bacterial Strains and Other Materials 
Strains of microorganisms used in this study were L. helveticus R0052 that 
was supplied by Rosell Institute Inc., Montreal, Canada (Lot# XA 0145, Seq# 
00014160) and H. pylori ATCC 43579 of human gastric origin that was provided by 
American Type Culture Collection (Rockville, MD).).  
4.3.3: Fermentation with Lactobacillus helveticus R0052 
Initially, 100 µL of L. helveticus R0052 frozen stock were inoculated into 10 
mL of MRS broth (Difco) and incubated at 37 ˚C for 16 h. A hundred microliter of the 
overnight grown strain were sub cultured to 10 mL of MRS broth, incubated at 37 ˚C 
28 
 
for 16 h and used as an inoculum. An inoculum size of 10% (v/v) was added 
aseptically to the 100% Bartlett pear juice, 100% Kiowa blackberry juice, or the 
70:30 P:BB combination to achieve a total volume of 90 mL in a 125-mL sterile 
Erlenmeyer flask. Initial pH was measured and adjusted to 6 using 1N NaOH at 0h 
fermentation. Fermentation was performed at 37 ˚C and 13 mL of samples were 
taken out at 0, 24 and 48 h. At every time point, the inoculated sample was placed 
into 2 different tubes. Prior to any assays, one tube was adjusted to pH 6 using 1N 
NaOH, while the pH of another tube was not adjusted (labeled as fermented acidic 
pH) and added with distilled water to keep the volume same. All samples were then 
centrifuged at 15,000g for 15 min and used for the assays. 
4.3.4: Absorbance of Samples and Colony Counts 
These measurements were done before the final pH treatment. Turbidity of 
the fermented samples at every time point as an indicator of bacterial growth was 
estimated using absorbance at 600 nm. More accurate estimation of living cells were 
made by plate count technique and expressed as CFU/mL. At 0, 24 and 48 h, 100 µL 
of the appropriate dilution were plated on MRS Agar and incubated at 37 ˚C for 24 h. 
Individual colonies were counted in the valid range of 25-250 to determine the 
CFU/mL of each sample.  
4.3.5: Total Phenolics Assay 
Total phenolic content of pear, blackberry, and pear/blackberry juice 
combinations were determined using an assay modified by Shetty et al. (1995). A 
volume of 500 microliters of sample and 500 microliters of distilled water were 
transferred into a test tube and added with 1 mL of 95% ethanol, 5 mL of distilled 
water and 0.5 mL of 50% (v/v) Folin-Ciocalteau reagent, respectively. The mixture 
was left to incubate for 5 min, followed by the addition of 1 mL of 5% Na2CO3. After 
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thorough mixing, the reaction mixture was incubated in the dark for 60 min and the 
absorbance was read at 725 nm after this time had elapsed. Standard curves were 
generated using increasing concentrations of gallic acid in 95% ethanol. Absorbance 
values were converted to total phenolics and expressed as mg of gallic acid 
equivalent (GAE) per mL volume of the pear and blackberry combination. 
4.3.6: Antioxidant Activity by 1, 1-Diphenyl-2-Picrylhydrazyl (DPPH) Radical 
Inhibition Assay 
Antioxidant activities of pear and blackberry juices and their 70/30 
combination were measured using a modified DPPH radical inhibition assay 
(Cervato et al., 2000). In a microcentrifuge tube, a volume of 0.25 mL sample 
mixture was added to 1.25 mL of 60 µM DPPH in 95% ethanol. During 5 min of 
incubation, the samples were vortexed and then centrifuged at 15,000g for 1 min. 
The absorbance (A) was read at 517 nm. As a control, 0.25 mL of 95% ethanol was 
used instead of a sample mixture. The antioxidant activity was expressed as % 
inhibition of DPPH radical formation and calculated using the following formula: 
 
4.3.7: α-Glucosidase Inhibition Assay 
The α-glucosidase inhibition assay was performed by mixing 50 µL of sample 
and 100 µL of 0.1 M phosphate buffer containing (pH 6.9) containing α-glucosidase 
enzyme solution (1.0 U/mL) in 96-well plates. The mixture solutions were 
incubated at 25 °C for 10 min. After incubation, 50 µL of 5 mM p-nitrophenyl-α-D-
glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was added to each well 
at timed intervals. The reaction mixtures were incubated at 25 °C for 5 min. Before 
and after that 5 min incubation, absorbance (A) reading were recorded at 405 nm by 
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micro plate reader (Thermomax, Molecular Device Co., VA, USA) and the difference 
between 0 and 5 min readings were noted as ΔA. For the control, 50 µL of buffer 
solution was added instead of sample. The result was expressed as % inhibition of 
α-glucosidase and calculated using the following formula: 
 
4.3.8: α-Amylase Inhibition Assay 
Two doses were tested in this assay, a total volume of 500 µL comprised of 
100 µL of sample and 400 µL of distilled water (1/5 concentration) or 50 µL of 
sample combined with 450 µL of distilled water (1/10 concentration). The water 
and sample mixtures were combined with 500 µL of 0.02 M sodium phosphate 
buffer (pH 6.9 with 0.006 M sodium chloride) containing α-amylase enzyme solution 
(0.5 mg/mL) were incubated at 25 °C for 10 min. After incubation, 500 µL of 1% 
(w/v) starch solution in 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M 
sodium chloride) was added to each tube at timed intervals and then incubated at 
25 °C for 10 min. The reaction was stopped with the addition of 1.0 mL of 
dinitrosalicylic acid color reagent. The test tubes were incubated in a boiling water 
bath for 10 min and then cooled down to room temperature. The reaction mixture 
was then diluted with 10 mL of distilled water and the absorbance (A) was read at 
540 nm. The result was expressed as % inhibition of α-amylase and calculated using 
the following formula: 
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4.3.9: Angiotensin-1- Converting Enzyme (ACE) Inhibition Assay 
The ACE inhibition activity was measured using a modified Cushman and 
Cheung (1971) method. A volume of 50 µL of sample was incubated with 200 µL of 
0.1 M NaCl-borate buffer (pH 8.3) containing 2.0 mU ACE-I solution at 25 °C for 10 
min. After incubation, 100 µL of 5 mM substrate solution (hippuryl-histidine-
leucine, HHL) was added. The reaction mixture was incubated at 37 °C for an hour. 
The reaction was then stopped with the addition of 150 µL of 0.5 N HCl. The product 
of ACE reaction, hippuric acid, was detected and quantified using HPLC.  
Five microliters of sample was injected using Agilent ALS 1100 autosampler 
into an Agilent 1100 series HPLC (Agilent Technologies, Palo Alto, CA) equipped 
with DAD 1100 diode array detector. The solvents used for gradient elution were 
(A) 10 mM phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol 
concentration was increased to 60% for the first 8 min and to 100% for the next 5 
min, then decreased to 0% for the last 5 min (total run time is 18 min). The 
analytical column used was Nucleosil 100-5C18, 250x4.6 mm i.d., with packing 
material of 5 µm particle size at a flow rate 1 mL/min at ambient temperature. 
During each run, the chromatogram was recorded at 228 nm and integrated using 
Agilent Chemstation enhanced integrator for detection of liberated hippuric acid. 
The peak area of hippuric acid (E) chromatogram was noted. Pure hippuric acid was 
used to calibrate the standard curve and retention time. The result was expressed as 
% inhibition of ACE and calculated using the following formula: 
 
 
 
32 
 
4.3.10: HPLC Analysis of Phenolic Profiles  
Two ml of pear, blackberry or the 70/30 juice mixture was filtered through a 
0.2 µm filter. A volume of 5 µL sample was injected using Agilent ALS 1100 
autosampler into an Agilent 1100 series HPLC (Agilent Technologies, Palo Alto, CA) 
equipped with DAD 1100 diode array detector. The solvents used for gradient 
elution were (A) 10 mM phosphoric acid (pH 2.5) and (B) 100% methanol. The 
methanol concentration was increased to 60% for the first 8 min and to 100% over 
the next 7 min, then decreased to 0% for the next 3 min and was maintained for the 
next 7 min (total run time is 25 min). The analytical column used was Agilent Zorbax 
SB-C18, 250x4.6 mm i.d., with packing material of 5 µm particle size at a flow rate of 
1 mL/min at ambient temperature. During each run, the chromatogram was 
recorded at 225 nm and 306 nm and integrated using Agilent Chemstation enhanced 
integrator. Pure standards of gallic acid, protocatechuic acid, chlorogenic acid, 
caffeic acid, resveratrol, rutin, p-coumaric acid, m-coumaric acid and rosmarinic acid 
in 100% methanol were used to calibrate the standard curves and retention times.  
4.3.11 Preparation of H. pylori Culture 
Culture of H. pylori was grown according to Stevenson et al. (2000). Standard 
plating medium was composed of 10 g of special peptone (Oxoid Ltd, Basing-Stoke, 
England), 15 g of granulated agar (Difco Laboratories, Becton, Dickinson and Co., 
Sparks, MD, USA), 5 g of sodium chloride (EM Science, Gibbstown, NJ, USA), 5 g of 
yeast extract (Difco) and 5 g of beef extract (Difco) per liter of water. Broth media 
were consisted of 10 g of special peptone (Oxoid Ltd) per liter, 5 g of sodium 
chloride (EM Science) per liter, 5 g of yeast extract (Difco) per liter and 5 g of beef 
extract (Difco) per liter of water. One milliliter of H. pylori stock culture was 
inoculated to 10 mL of sterile broth medium and incubated at 37 ˚C for 24 h. The 
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active culture was then spread on H. pylori standard plating agar plates to make 
bacterial lawn for the agar-diffusion assay.  
4.3.12: Agar-Diffusion Assay 
The antimicrobial activity of the fermented sample extracts on H. pylori was 
analyzed by agar-diffusion method. Sterile 12.7 mm diameter paper disks 
(Schleicher & Schuell, Inc., Keene, NH) were placed on the surface of seeded agar 
plates. The test extracts were sterilized using 0.22 µm Milipore filter membrane 
(Fisher Scientific, Pittsburgh, PA). One hundred microliters of test extracts were 
aseptically added onto the paper disks. Distilled water was used as control. Treated 
plates were incubated at 37 ˚C for 48 h in BBL GasPak jars (Becton, Dickinson and 
Co., Sparks, MD) with BD GasPak Campy container system sachets (Becton, 
Dickinson and Co., Sparks, MD). Each experiment was repeated twice and consisted 
of triplicates (3 disks per sample or treatment in 1 plate). Diameter (D) of clear zone 
surrounding each disk was measured (in millimeter). The result was expressed as 
an index of inhibition using the following formula. 
4.3.13: Proline Growth Response Assay 
The inhibition mechanism of H. pylori mediated by phenolic phytochemicals 
was proposed by Shetty and Wahlqvist (2004). Bacterial lawns of H. pylori were 
prepared as described previously. The standard plating medium was modified by 
the addition of Proline to a final concentration of 5 mM. A similar protocol as 
mentioned in the agar-diffusion assay was followed. 
4.3.14: Statistical Analysis 
All experiments were performed in triplicate and repeated three times each.  
Means and standard errors were calculated from the replicates within the 
experiments and analyzed using Microsoft Excel XP. Significant differences were 
determined using one way ANOVA, then least significant difference test at p < 0.05.  
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For all assays except the phenolic profiles, the results were compared using a 
basic mathematical calculation. The results generated by various formulas were 
dependent on the combination ratios of 100% Kiowa blackberry juice and 100% 
Bartlett pear juice.  
4.4: Results and Discussion 
4.4.1: Total Soluble Phenolics 
 At 100% juice, Kiowa blackberries had the highest total soluble phenolic 
(TSP) content, and Bartlett pears had the least (Figure 1). While the blackberry 
control had the highest average findings for TSP, they quickly dissipated over 48 
hours.  Adjustment to a pH of 6 lowered the overall stability of phenols in solution, 
while fermentation by lactic acid bacteria increased this stability. The 70:30 
combinations showed good phenolic content while also proving to be very stable 
over time, as opposed to blackberries. The change for the pH adjusted samples 
increased or decreased over 48 hours, but not to the same extent as the unmodified 
fermented samples. The lessened changes held true between all pH and non-pH 
adjusted samples for all substrates. Overall, the pH adjustment lessens the 
availability of the measurable bioactive phenolic compounds within these fruit 
samples. 
 As seen in Figure 1, the amount of soluble phenolics increased steadily as the 
fermentation time increased in pear. These phenolic compounds are very versatile 
in their abilities to inhibit metabolic enzymes and quench oxidative species; an 
increase in phenols is directly proportional to an increase in health benefits for the 
fruit juices. 
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 Blackberries are naturally high in phenolic compounds, the bacteria decrease 
the available soluble phenols at 0 hours most likely due to immediate oxidation 
managing reactions that they create, which would quench the antioxidants. Over 
time, the amount and availability of antioxidants becomes more stable than the 
control which is likely due to a combination of pH changes and bacterial metabolic 
effect. 
 
Figure 1: TSP reading for 100% Pear, 70:30 Pear:Blackberry, and 100% 
Blackberry samples. Blackberry shows the highest amount of soluble phenolic 
compounds, pear shows the least.  
4.4.2: DPPH 
 Antioxidant activity was high for every combination of fruits, but the 
fermented 70:30 pear:blackberry combination showed the highest results for the 
DPPH assay (Figure 2).  Fermentation almost always increased the ability of the 
fruits to improve antioxidant effects. As shown in Figure 2, the control of the 48 
hours pear sample far exceeded the 48 hour fermented and pH adjusted samples. 
When pH was adjusted, it usually lowered the ability of the fermented juice to 
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function in regards to the antioxidants, with the exception of the 48 hour blackberry 
sample. This would indicate that modified pH plays an important role in the ability 
of these enzymes to function. 
 Antioxidant activities always increased with the addition of lactic acid 
bacteria. The exact amount of time that it takes to reach peak inhibition changes 
with each different fruit juice, but the trend upwards with the addition of LAB is 
consistent. Also of note is the obvious increase of antioxidant activity of the pear and 
70:30 control samples over time, where in the blackberry it decreased. Reasons for 
these changes are likely due to pH modifications and the addition of lactic acid to the 
juices. Lower pH seems to increase the ability of blackberry phenolics to function 
against DPPH while hindering the pear phenolic compounds. Even without 
fermentation, the antioxidant capacity of the control sample increased when pear 
juice was included in the sample. Prior experiments in our laboratory have led to 
similar conclusions in respect to the general ability of these fruits to all inhibit DPPH 
at a moderate to high level. 70:30 pear:blackberry was shown to have improved 
results over the pure 100% pear and 100% blackberry samples in previous research 
as well (Warner, 2010). 
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Figure 2: DPPH inhibition results, showing high inhibition for all fruit 
substrates. 70:30 had the highest results, followed by 100% blackberry. 100% 
Pear had the lowest readings for DPPH inhibition. 
4.4.3: Alpha-Glucosidase 
 Initially, pear had the highest alpha-glucosidase activity; but when fermented 
for 24 or 48 hours, the blackberries quickly surpass pear (Figure 3). Pear also 
exhibited the greatest decrease of activity in regards to dose-response. Blackberry 
exhibits excellent inhibition when undiluted, but dose-response can quickly drop 
when dilution occurs. Fermented 70:30 had the highest stability, especially under 
dilution, after 48 hours. This could be attributed to a synergistic relationship 
between compounds within pears and blackberries, or perhaps just a more 
successful fermentation within regard to alpha-glucosidase when there are multiple 
types of fruit substrates. 
 Fermentation over longer periods of time benefits the 70:30 combination and 
100% blackberry juice the most. Blackberries could therefore be postulated to have 
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compounds that increase the bioactive benefit of alpha-glucosidase inhibition when 
exposed to lactic acid fermentation; whereas the initially high alpha-glucosidase 
inhibition found in pear juice was consumed by the bacteria. Previous studies have 
had similar results with regard to pH and fermentation time versus inhibition 
(Augustinah, 2012). 
 
 
 
Figure 3: Alpha-glucosidase inhibition for the substrates with fermentation. 
Samples were undiluted (ND), 50% diluted (1/2D) and diluted to 1/5 
concentration (1/5D). The inhibition usually peaked at 48 hours, with 
exception of the pear samples and the highest diluted blackberry sample. 
4.4.4: Alpha-Amylase 
 Pear exhibited complete inhibition of alpha-amylase when fermented, while 
blackberry exhibited relatively little in any circumstance (Figure 4). A 70:30 
combination was balanced between the two extremes, with good results under 
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fermentation and poor effects when pH adjusted. When blackberry was fermented, 
it seems to lose inhibitory effects in some cases. Alpha-amylase inhibition was 
lowered in almost all results when the pH is adjusted to 6.0.  
 Inhibition of alpha-amylase peaks at the 24 hour timeframe of fermentation 
for 100% pear juice, and at 48 hour timeframe for 100% blackberry juice. The 70:30 
pear:blackberry juice has a more interesting profile, as it peaks at 48 hours but only 
when left at a lower dilution. At a highly diluted state, the 48 hour fermentation 
shows little to no activity, unless pH adjusted. Similar results were found in previous 
results for pear having a prolific ability to inhibit alpha-amylase under all 
circumstances, while blackberry had relatively very little ability.  
 
Figure 4: Alpha-amylase inhibition by fermented and non-fermented fruit 
juices. Substrate was diluted to 1/5 (1/5D) and 1/10 (1/10D) concentrations. 
Pear showed the highest inhibition of alpha-amylase, followed by the 70:30 
pear: blackberry combination. Blackberry showed poor inhibition overall. 
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4.4.5: Angiotensin Converting Enzyme 
 ACE inhibition was best in pears, and almost negligible in blackberry: hence 
the reason blackberries were omitted entirely from Figure 5. Fermentation 
increased ACE inhibition in all cases except for diluted 70:30. A pH adjustment 
lowered ACE inhibition in all cases and diluted pH adjusted and fermented 70:30 
showed no inhibitory effects. 
 The distinction between fermented non-pH adjusted and fermented pH 
adjusted was smaller than the difference between fermented and non-fermented 
fruit juices. Even with modification to reduce acidity, the fermentation still showed 
benefits for ACE inhibition when compared to the control samples.  
 
Figure 5: ACE inhibition using 100% pear and 70:30 pear:blackberry 
substrates. 100% blackberry was omitted due to negligible inhibition levels. 
Samples were undiluted (ND), or diluted to 50% (1/2D). 100% pear shows 
high inhibition, especially after fermentation. 
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4.4.6: H. pylori 
 Helicobacter pylori was only inhibited by fermented 100% blackberry (Figure 
6). No other sample inhibited the growth of H. pylori whatsoever. Longer 
fermentation caused greater results by zone of inhibition testing. 
 The reason behind this inhibition is still not clear. pH was not the suspected 
cause, as all samples were pH adjusted prior to plating. Most phenolic compounds 
prevent bacteria from utilizing proline dehydrogenase to obtain proline for energy 
needs; to understand this likely metabolism strategy, H. pylori was grown on plates 
containing proline to supplement the bacteria. Even on these plates, the bacteria 
remained inhibited solely by fermented blackberry juice. The 70:30 combination 
juices also had very little effect on H. pylori, even though it contained 30% 
blackberry juice. A compound in the Bartlett pear juice may be preventing the Kiowa 
blackberry juice from functioning as an inhibitor.  
 
 
 
 
 
 
 
Figure 6: A lawn plate of H, pylori with four sterile filter papers placed on top. 
These papers were infused with 48 hour fermented blackberry juice. The area 
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of inhibition around the three infused papers shows clear inhibition of 
growth, while the control (bottom left) shows none. 
4.5: Conclusion 
 Fermentation increases the stability of phenolic compounds and their 
functionality in pear and blackberry juices, as well as the 70:30 P:BB  combination. 
This was most likely caused by the production of compounds due to bacterial 
growth and pH changes due to the formation of lactic acid.  
 The 70:30 P:BB combination showed promising results in improving glucose 
metabolism and stability, especially after fermentation. Stability was increased in 
every measured assay that was tested in this study. Alpha-amylase, alpha-
glucosidase, ACE, soluble phenolics, and antioxidant capacity were all stable with 
the ratio of 70 % Bartlett pear and 30% Kiowa blackberry juices after fermentation 
for 48 hours. 
 A 100% blackberry juice inhibited the proliferation of H. pylori on an agar 
plate when fermented by L. helveticus. This is postulated to be due to some form of 
protonation effect that is caused by L. helveticus when grown in blackberries. Pear 
juice does not exhibit the same effects, and the 70:30 pear:blackberry mixture 
likewise does not have any ability of halt the growth of H. pylori; even though there 
is blackberry juice in the combination. Varying levels of proline was used in 
additional plates to test if the amino acid would affect the ability of H. pylori to be 
inhibited by phenolics, but it did not alter the results whatsoever. Proline 
dehydrogenase inhibition is therefore ruled out as the reason for the inability of H. 
pylori to grow around 100% blackberry juice fermented with L. helveticus. 
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CHAPTER 5 
IMPROVMENT OF FUNCTIONAL BIOACTIVITY IN PEAR:BLACKBERRY 
SYNERGIES FOR TYPE 2 DIABETES AND HYPERTENSION UTILIZING 
BIFIDOBACTERIUM LONGUM 
FERMENTATION 
5.1: Abstract 
 In this study, Bifidobacterium longum was utilized to ferment juices sourced 
from Bartlett pear and Kiowa blackberries. Bifidobacterium longum is a known 
probiotic, and should also potentially increase the phenolic content and related 
bioactivities of the fruit juices being evaluated for health benefits. This study is a 
continuation of the previous investigation which utilized Lactobacillus helveticus, 
another lactic acid producing bacterium. Evaluating the same fruit juices will allow 
for the comparison of benefits between similar organisms but with overall differnet 
metabolic capabilities as Bifidobacterium is more oxygen sensitive. The secondary 
goal of the experiment is to validate if any of these fruit juices, when fermented with 
B. longum, can inhibit the growth of Helicobacter pylori; which is a common 
bacterium found in the gut that can cause ulceration of the stomach and duodenum 
and can subsequently lead to potential cancer development in the aforementioned 
organs. 
 Over the course of the study, results showed that the 70:30 combinations had 
good synergy, the highest content of soluble phenolics, higher antioxidant activity, 
and the fermentation with B. longum leading to higher phenolic activity retention 
over time. Fermentation increased the potency of phenolic compounds in regards to 
their ability to inhibit certain key digestive enzymes associates with type 2 diabetes 
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and demonstrated an increased stability of the phenolic bioactives. A 100% Kiowa 
blackberry juice was shown to inhibit the growth of H. pylori, but only after 
fermentation. The control showed no inhibition whatsoever, nor did any 70:30 
combinations or 100% Bartlett pear show any inhibition of the bacterium either. 
The 70:30 combinations are the most cost-effective way to reap the greatest 
benefits of the fruits studied. Fermentation with B. longum increases this cost-
effectiveness by adding shelf life and additional health benefits. 
5.2: Introduction 
Bifidobacterium longum is a bacterium commonly used as probiotics in 
cultured yogurts along with other lactic acid bacterial fermentation such as 
Lactobacillus bulgaricus.  In this study Bifidobacterium longum was utilized in order 
to compare phenolic content and associate bioactive capabilities of a fermented 
juice from Bartlett pear and Kiowa blackberry to their non-fermented counterparts. 
The aim is to increase the ability of the juice to inhibit the alpha-amylase, alpha-
glucosidase and angiotensin converting enzymes while also evaluating if the 
antioxidant functions are affected by the fermentation.  This experiment was 
conducted in order to examine the bioavailability and stability of phenolic 
compounds that are naturally found in fruits when fermentation is involved. These 
phenolic compounds are important in the inhibition of key metabolic enzymes that 
break down carbohydrates within the digestive system. The reasoning behind 
inhibiting carbohydrate metabolizing enzymes is to slow the absorption of sugar 
into the body from digestion to reduce insulin shock and other metabolic damage to 
counter the development of Type 2 diabetes mellitus in humans.  Refined sugars are 
quickly absorbed into the blood, causing a spike in blood glucose. These spikes in 
glucose can cause insulin resistance in cells over time, which is a factor in 
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developing Type 2 diabetes mellitus. Altering and slowing glucose metabolism is a 
key way to avoid these sugar spikes in the blood by slowing their uptake rate in the 
intestines.  
 When glucose is absorbed into the bloodstream, insulin is produced by the 
pancreatic beta-cells to keep blood sugar regulated. When too much glucose is 
absorbed, insulin production must also increase. If the pancreas is overworked for 
too long of a period, cellular damage can occur in the organ. The body can also 
become resistant to insulin in the same way that it acclimates to any change in 
atmosphere. This acclimation to the sustained production of insulin can lead to 
insulin resistance, and then ultimately beta-cell dysfunction as the beta-cells of the 
pancreas are overworked even further (Ceriello, 2000). 
 Phenolic compounds within fruits can also inhibit the angiotensin converting 
enzyme, which can cause oxidative stress and hypertension. Hypertension is a co-
factor for the development of Type 2 diabetes mellitus, and is seen as a co-morbid 
disease due to the increased chance of developing one of the conditions when the 
person already has the other. One way of developing hypertension is through the 
renin-angiotensin-aldosterone pathway which occurs naturally to regulate blood 
pressure. The angiotensin converting enzyme in the body converts angiotensin I, an 
inert compound, to angiotensin II which increases blood pressure and can lead to 
hypertension. Managing ACE in the blood can help alleviate hypertension by stalling 
the production of angiotensin II (DeFronzo, 1999) . 
 Bartlett pear and Kiowa blackberries have been studied previously in this 
laboratory, and have been shown to effectively reduce glucose metabolism enzymes 
like alpha-amylase and alpha glucosidase using in vitro models (Warner, 2012). As a 
supporting evidence to the historical preservation and stability aspect of lactic acid 
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fermentation, the change in total soluble phenolic content over time will be 
monitored to investigate if the biological function of the phenolics present in the 
juice is preserved along with the juice itself. Phenolic compounds are what is 
inhibiting the enzymes and are also partly responsible for the antioxidant properties 
of the fruit juices. The preservation of phenolic activity over time would increase the 
shelf life of a product with regard to the nutritional properties it exhibits. This 
preservation technique could also be further utilized to repurpose fruits that would 
not be consumed before their expiration, which would increase economic profits 
and decrease losses due to spoilage. 
  5.3: Materials and Methods 
 The enzymes, α-glucosidase from yeast S. cerevisiae(EC 3.2.1.20), porcine 
pancreatic α-amylase (EC 3.2.1.1) and angiotensin-1-converting enzyme from rabbit 
lung (EC 3.4.15.1) were purchased from Sigma Chemical Co. (St. Louis, MO). Unless 
noted, all chemicals were also purchased from Sigma Chemical Co. (St. Louis, MO). 
The Bartlett pear was sourced from a local Big Y supermarket, while the 
Kiowa Blackberries were from the Arkansas Agricultural Experiment Station 
breeding program via Auburn University in Alabama. 
5.3.1: Sample Preparation 
Fresh Bartlett pears were homogenized using a Waring blender for 3 min and 
subsequently the supernatant of the pear was collected following centrifugation at 
15,000g for 15 min. Thawed blackberry fruit was homogenized for 3 min using a 
Waring blender and then centrifuged two times at 15,000g for 15 min each to 
produce a clear juice. Supernatants were collected and stored at -20 °C during the 
period of study. The pear and blackberry supernatants were either used as 100% 
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pure samples, or combined at a ratio of 70/30. Pear and blackberry juice alone were 
used as controls. Some combinations and controls were prepared in the adjusted pH 
6 (with several drops of 0.1N NaOH) while some were used with natural acidic pH 
conditions. The juices were stored at 4 °C during their analysis. 
5.3.2: Bacterial Strains and Other Materials 
Strains of microorganisms used in this study were Bifidobacterium longum 
isolated from a previous study (Apostolidis et al. 2007) and H. pylori ATCC 43579 of 
human gastric origin that was provided by American Type Culture Collection 
(Rockville, MD 
5.3.3: Fermentation with Bifidobacterium longum 
Initially, 100 µL of B. longum frozen stock were inoculated into 10 mL of MRS 
broth (Difco) and incubated at 37 ˚C for 16 h. A hundred microliter of the overnight 
grown strain were sub cultured to 10 mL of MRS broth, incubated at 37 ˚C for 16 h 
and used as an inoculum. An inoculum size of 10% (v/v) was added aseptically to 
the 100% Bartlett pear juice, 100% Kiowa blackberry juice, or the 70:30 P:BB 
combination to achieve a total volume of 90 mL in a 125-mL sterile Erlenmeyer 
flask. Initial pH was measured and adjusted to 6 using 1N NaOH at 0h fermentation. 
Fermentation was performed at 37 ˚C and 13 mL of samples were taken out at 0, 24 
and 48 h. At every time point, the inoculated sample was placed into 2 different 
tubes. Prior to any assays, one tube was adjusted to pH 6 using 1N NaOH, while the 
pH of another tube was not adjusted (labeled as fermented acidic pH) and added 
with distilled water to keep the volume same. All samples were then centrifuged at 
15,000g for 15 min and used for the assays. 
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5.3.4: Absorbance of Samples and Colony Counts 
These measurements were done before the final pH treatment. Turbidity of 
the fermented samples at every time point as an indicator of bacterial growth was 
estimated using absorbance at 600 nm. More accurate estimation of living cells were 
made by plate count technique and expressed as CFU/mL. At 0, 24 and 48 h, 100 µL 
of the appropriate dilution were plated on MRS Agar and incubated at 37 ˚C for 24 h. 
Individual colonies were counted in the valid range of 25-250 to determine the 
CFU/mL of each sample.  
5.3.5: Total Phenolics Assay 
Total phenolic content of pear, blackberry, and pear/blackberry juice 
combinations were determined using an assay modified by Shetty et al. (1995). 500 
microliters of sample and 500 microliters of distilled water were transferred into a 
test tube and added with 1 mL of 95% ethanol, 5 mL of distilled water and 0.5 mL of 
50% (v/v) Folin-Ciocalteau reagent, respectively. The mixture was left to incubate 
for 5 min, followed by the addition of 1 mL of 5% Na2CO3. After thorough mixing, 
the reaction mixture was incubated in the dark for 60 min and the absorbance was 
read at 725 nm after this time had elapsed. Standard curves were generated using 
increasing concentrations of gallic acid in 95% ethanol. Absorbance values were 
converted to total phenolics and expressed as mg of gallic acid equivalent (GAE) per 
mL volume of the pear and blackberry combination. 
5.3.6: Antioxidant Activity by 1, 1-Diphenyl-2-Picrylhydrazyl (DPPH) Radical 
Inhibition Assay 
Antioxidant activities of pear and blackberry juices and their 70/30 
combination were measured using a modified DPPH radical inhibition assay 
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(Cervato et al., 2000). In a microcentrifuge tube, a volume of 0.25 mL sample 
mixture was added to 1.25 mL of 60 µM DPPH in 95% ethanol. During 5 min of 
incubation, the samples were vortex mixed and then centrifuged at 15,000g for 1 
min. The absorbance (A) was read at 517 nm. As a control, 0.25 mL of 95% ethanol 
was used instead of a sample mixture. The antioxidant activity was expressed as % 
inhibition of DPPH radical formation and calculated using the following formula: 
 
5.3.7: α-Glucosidase Inhibition Assay 
The α-glucosidase inhibition assay was performed by mixing 50 µL of sample 
and 100 µL of 0.1 M phosphate buffer containing (pH 6.9) containing α-glucosidase 
enzyme solution (1.0 U/mL) in 96-well plates. The mixture solutions were 
incubated at 25 °C for 10 min. After incubation, 50 µL of 5 mM p-nitrophenyl-α-D-
glucopyranoside solution in 0.1 M phosphate buffer (pH 6.9) was added to each well 
at timed intervals. The reaction mixtures were incubated at 25 °C for 5 min. Before 
and after that 5 min incubation, absorbance (A) reading were recorded at 405 nm by 
micro plate reader (Thermomax, Molecular Device Co., VA, USA) and the difference 
between 0 and 5 min readings were noted as ΔA. For the control, 50 µL of buffer 
solution was added instead of sample. The result was expressed as % inhibition of 
α-glucosidase and calculated using the following formula: 
 
5.3.8: α-Amylase Inhibition Assay 
Two doses were tested in this assay, a total volume of 500 µL comprised of 
100 µL of sample and 400 µL of distilled water (1/5 concentration) or 50 µL of 
sample combined with 450 µL of distilled water (1/10 concentration). The water 
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and sample mixtures were combined with 500 µL of 0.02 M sodium phosphate 
buffer (pH 6.9 with 0.006 M sodium chloride) containing α-amylase enzyme solution 
(0.5 mg/mL) were incubated at 25 °C for 10 min. After incubation, 500 µL of 1% 
(w/v) starch solution in 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M 
sodium chloride) was added to each tube at timed intervals and then incubated at 
25 °C for 10 min. The reaction was stopped with the addition of 1.0 mL of 
dinitrosalicylic acid color reagent. The test tubes were incubated in a boiling water 
bath for 10 min and then cooled down to room temperature. The reaction mixture 
was then diluted with 10 mL of distilled water and the absorbance (A) was read at 
540 nm. The result was expressed as % inhibition of α-amylase and calculated using 
the following formula: 
 
5.3.9: Angiotensin-1- Converting Enzyme (ACE) Inhibition Assay 
The ACE inhibition activity was measured using a modified Cushman and 
Cheung (1971) method. A volume of 50 µL of sample was incubated with 200 µL of 
0.1 M NaCl-borate buffer (pH 8.3) containing 2.0 mU ACE-I solution at 25 °C for 10 
min. After incubation, 100 µL of 5 mM substrate solution (hippuryl-histidine-
leucine, HHL) was added. The reaction mixture was incubated at 37 °C for an hour. 
The reaction was then stopped with the addition of 150 µL of 0.5 N HCl. The product 
of ACE reaction, hippuric acid, was detected and quantified using HPLC.  
Five microliters of sample was injected using Agilent ALS 1100 autosampler 
into an Agilent 1100 series HPLC (Agilent Technologies, Palo Alto, CA) equipped 
with DAD 1100 diode array detector. The solvents used for gradient elution were 
(A) 10 mM phosphoric acid (pH 2.5) and (B) 100% methanol. The methanol 
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concentration was increased to 60% for the first 8 min and to 100% for the next 5 
min, then decreased to 0% for the last 5 min (total run time is 18 min). The 
analytical column used was Nucleosil 100-5C18, 250x4.6 mm i.d., with packing 
material of 5 µm particle size at a flow rate 1 mL/min at ambient temperature. 
During each run, the chromatogram was recorded at 228 nm and integrated using 
Agilent Chemstation enhanced integrator for detection of liberated hippuric acid. 
The peak area of hippuric acid (E) chromatogram was noted. Pure hippuric acid was 
used to calibrate the standard curve and retention time. The result was expressed as 
% inhibition of ACE and calculated using the following formula: 
 
5.3.10: HPLC Analysis of Phenolic Profiles  
Two ml of pear, blackberry or the 70/30 juice mixture was filtered through a 
0.2 µm filter. A volume of 5 µL sample was injected using Agilent ALS 1100 
autosampler into an Agilent 1100 series HPLC (Agilent Technologies, Palo Alto, CA) 
equipped with DAD 1100 diode array detector. The solvents used for gradient 
elution were (A) 10 mM phosphoric acid (pH 2.5) and (B) 100% methanol. The 
methanol concentration was increased to 60% for the first 8 min and to 100% over 
the next 7 min, then decreased to 0% for the next 3 min and was maintained for the 
next 7 min (total run time is 25 min). The analytical column used was Agilent Zorbax 
SB-C18, 250x4.6 mm i.d., with packing material of 5 µm particle size at a flow rate of 
1 mL/min at ambient temperature. During each run, the chromatogram was 
recorded at 225 nm and 306 nm and integrated using Agilent Chemstation enhanced 
integrator. Pure standards of gallic acid, protocatechuic acid, chlorogenic acid, 
caffeic acid, resveratrol, rutin, p-coumaric acid, m-coumaric acid and rosmarinic acid 
in 100% methanol were used to calibrate the standard curves and retention times.  
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5.3.11 Preparation of H. pylori Culture 
Culture of H. pylori was grown according to Stevenson et al. (2000). Standard 
plating medium was composed of 10 g of special peptone (Oxoid Ltd, Basing-Stoke, 
England), 15 g of granulated agar (Difco Laboratories, Becton, Dickinson and Co., 
Sparks, MD, USA), 5 g of sodium chloride (EM Science, Gibbstown, NJ, USA), 5 g of 
yeast extract (Difco) and 5 g of beef extract (Difco) per liter of water. Broth media 
were consisted of 10 g of special peptone (Oxoid Ltd) per liter, 5 g of sodium 
chloride (EM Science) per liter, 5 g of yeast extract (Difco) per liter and 5 g of beef 
extract (Difco) per liter of water. One milliliter of H. pylori stock culture was 
inoculated to 10 mL of sterile broth medium and incubated at 37 ˚C for 24 h. The 
active culture was then spread on H. pylori standard plating agar plates to make 
bacterial lawn for the agar-diffusion assay.  
5.3.12: Agar-Diffusion Assay 
The antimicrobial activity of the fermented sample extracts on H. pylori was 
analyzed by agar-diffusion method. Sterile 12.7 mm diameter paper disks 
(Schleicher & Schuell, Inc., Keene, NH) were placed on the surface of seeded agar 
plates. The test extracts were sterilized using 0.22 µm Milipore filter membrane 
(Fisher Scientific, Pittsburgh, PA). One hundred microliters of test extracts were 
aseptically added onto the paper disks. Distilled water was used as control. Treated 
plates were incubated at 37 ˚C for 48 h in BBL GasPak jars (Becton, Dickinson and 
Co., Sparks, MD) with BD GasPak Campy container system sachets (Becton, 
Dickinson and Co., Sparks, MD). Each experiment was repeated twice and consisted 
of triplicates (3 disks per sample or treatment in 1 plate). Diameter (D) of clear zone 
surrounding each disk was measured (in millimeter). The result was expressed as 
an index of inhibition using the following formula. 
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5.3.13: Proline Growth Response Assay 
The inhibition mechanism of H. pylori mediated by phenolic phytochemicals 
was proposed by Shetty and Wahlqvist (2004). Bacterial lawns of H. pylori were 
prepared as described previously. The standard plating medium was modified by 
the addition of Proline to a final concentration of 5 mM. A similar protocol as 
mentioned in the agar-diffusion assay was followed. 
5.3.14: Statistical Analysis 
All experiments were performed in triplicate and repeated three times each.  
Means and standard errors were calculated from the replicates within the 
experiments and analyzed using Microsoft Excel XP. Significant differences were 
determined using one way ANOVA, then least significant difference test at p < 0.05.  
For all assays except the phenolic profiles, the results were compared using a 
basic mathematical calculation. The results generated by various formulas were 
dependent on the combination ratios of 100% Kiowa blackberry juice and 100% 
Bartlett pear juice.  
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5.4 Results and Discussion 
5.4.1: Total Soluble Phenolics 
 
Figure 7: Total soluble phenolics for B. longum fermented substrate and 
control substrate. 100% pear shows lower levels than blackberry overall. 24 
hours after blending shows the best results. 
Phenolic contents of some fruit juices increased substantially with 
fermentation by B. longum. In this case, the 24 hour samples appear to exhibit the 
highest amount of soluble phenolic compounds in both fermented and non-
fermented juices. It could be assumed that after 24 hours the bacteria begin to 
degrade the phenols with lactic acid or other metabolic byproducts along with light 
and heat degradation. Pear juice naturally contained the least phenolic compounds, 
while blackberry had the most. A 70:30 pear:blackberry combination was naturally 
between the two, but had a very good bioactive potential when fermented with B. 
longum. A 70:30 combination had the highest increase of total soluble phenolics 
after fermentation for 24 hours, without pH adjustment the amount of soluble 
phenolics more than doubled. The ability of B. longum to affect total soluble 
phenolics in fruit juices should be investigated further. Evaluating after holding the 
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juices for 72 hours at 37 ° C may yield interesting results on phenolic longevity and 
associated shelf life of overall bioactive potential. 
5.4.2: DPPH 
 
Figure 8: DPPH inhibition assay for the substrates. Samples were fermented 
with B. longum (BL), fermented and also modified to a steady pH of 6.2 (pH) 
and left unfermented (Control). Inhibition was measured at 0, 24 and 48 
hours. Strong inhibition overall, with 70:30 pear: blackberry showing the 
highest overall results. 
 Juices evaluated by the DPPH radical scavenging oxidative stress test showed 
good results in all assays at all times. The lowest amount of inhibition was around 
55% by the pear control juices; while the highest results were from 70:30 
fermented with B. longum which were measured upwards of 80% inhibition. A 
70:30 pear:blackberry juice had the best indicators in almost all aspects of free 
radical quenching. Pear juice seemed to be affected the most by fermentation, with 
good increases in radical quenching ability when compared to the control. 
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Blackberry had relatively good bioactive potential with and without fermentation by 
B. longum.  
5.4.3: Alpha-Glucosidase 
 
Figure 9: Alpha-glucosidase inhibition for the substrates with fermentation. 
Samples were undiluted (ND), 50% diluted (1/2D) and diluted to 1/5 
concentration (1/5D). The inhibition usually peaked at 48 hours, with 
exception of the pear samples and the highest diluted blackberry sample. 
Alpha-glucosidase inhibition was highest in 48 hour blackberry, while being 
relatively weak in fermented pear juice. Fermentation increased the alpha-
glucosidase inhibitory effects of the plant phenolics tested in this experiment with 
the exception of pear juice. Pear juice actually seemed to decrease in inhibitory 
ability when left to ferment over time. At 48 hours time, the strongest inhibitor was 
blackberry, while the weakest happened to be pear; but interestingly enough it 
seemed that pear was almost as strong as blackberry when measured at 24 hours. 
Something occurs between 24 and 48 hours in pear juice which renders it an 
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ineffective alpha-glucosidase inhibitor. A 70:30 combination possesses strong 
inhibitory abilities which decreases at 24 hours but then surges to a peak at 48 
hours. This seems to be a direct opposite of the pear juice which weakens after 48 
hours elapses. A 70:30 also performed the best out of all diluted juices after 48 
hours time.  
5.4.4: Alpha-Amylase 
 
Figure 10: Alpha-amylase inhibition for samples with B. longum and control 
samples without added bacteria. The highest results show up at the 24 hour 
mark with100%  pear having the highest overall results on average. 
Alpha-amylase results for B. longum were rather erratic in nature. The most 
conclusive results from this experiment showed that after 24 hours, most juices 
showed higher inhibition of alpha-amylase, but it often dropped in inhibitory 
effectiveness after 48 hours with exception of in some blackberry samples. The 
increased effect at 24 hours was true even for the non-fermented versions of the 
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fruit juice. This would imply that there could be a reaction with the fruit juice and 
the atmosphere or raised temperature that increased its ability to counteract alpha-
amylase after one day of holding. It seems that no conclusive evidence can be drawn 
from these experiments on the viability of B. longum to affect a juices ability to 
inhibit alpha-amylase with exception of undiluted blackberry juice. 
5.4.5: ACE 
 
Figure 11: ACE inhibition using 100% pear and 70:30 pear:blackberry 
substrates. 100% blackberry was omitted due to negligible inhibition levels. 
Samples were undiluted (ND), or diluted to 50% (1/2D). 100% pear shows 
high inhibition, especially after fermentation. 
 Angiotensin converting enzyme inhibition highest in pear juice while being 
moderately lower in the 70:30 pear:blackberry juice combination. The reason for 
70:30 being lower in potential ACE inhibition is the relatively non-existent ability of 
blackberry juice to affect ACE. The inability of blackberry juice to affect ACE is the 
reason behind not having it translate into measurable results. There is definite dose 
dependence for ACE inhibition in 70:30 combination, as these results will show. 
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Pear on the other hand suffers much less from dose dependence, especially for the B. 
longum fermented juice. Adjusting the pH of the pear juice seemingly augments the 
juice to be more dose dependent. 
5.4.6: Helicobacter pylori 
 Plates of Helicobacter pylori were treated with Bifidobacterium longum 
fermented juices and their non-fermented control samples as well, what was 
recorded in this experiment closely reflected the previous L. helveticus findings. 
Kiowa blackberry that was fermented for 48 hours had relatively strong rates of 
inhibition on H. pylori. This experiment was then tested again with plates containing 
proline, to test the proline pathway. These plates showed the same results of Kiowa 
blackberry inhibition and no other juice variety having any effects. Another 
experiment with H. pylori was done to test if acidity had any bearing on the 
inhibition. H. pylori lawn plates were seeded with filter paper containing blackberry 
juice control modified to have the same pH as the fermented juice. The findings from 
the growth of those plates showed no inhibition whatsoever, further solidifying the 
fact that the blackberry juice requires fermentation by a lactic acid bacterium in 
order to inhibit H. pylori. The exact mechanism for why fermentation of 100% 
Kiowa blackberry juice inhibits the growth of H. pylori is enigmatic at this point, but 
further research could uncover interesting results and potential treatments for the 
pathogen.  
5.5: Conclusion 
Utilizing Bifidobacterium longum as a fermentative organism in the juice of 
pear, blackberry and a respective 70:30% combination of the two fruits generally 
increased the ability of the juices to affect the metabolic syndrome related pathways 
using in vitro models. To help prevent the metabolic syndrome from occurring in 
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humans, at least with dietary moderation, these fermented fruit juices could 
perform as a reasonably potent metabolic moderator. Fermentation with B. longum 
affects the ability of these aforementioned fruit juices to perform metabolic enzyme 
inhibition in a positive overall manner. Fermentation also increases the bioactive 
stability of phenolic compounds over time.  The findings of this experiment show 
that a probiotic dietary supplement involving lactic acid bacteria, pear and 
blackberry juices is a viable suggestion for improving community health in the 
context of type 2 diabetes and its complications. Between the fruit juices and 
bacteria the supplement would be affordable for poor communities and could help 
provide additional dietary strategies to counter type 2 diabetes which unusually 
affects them in so-called food and nutritional deserts due to overabundance of 
inexpensive refined carbohydrates.  
Nothing would be a miracle-cure, but this preventative supplement could be 
dispersed with little expense with careful budgeting and efficient distribution 
systems. This is also a “low-tech” food in the sense that it could be easily produced 
in less developed countries. All which is required is: fruits, bacteria and physical 
crushing of said fruit. The bacteria would enable the key bioactive benefits in this 
situation through its fermentation metabolic pathways. 
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